CYP2D6 gene variants in urban/admixed and Amerindian populations of Venezuela: Pharmacogenetics and anthropological implications

Annals of Human Biology

Volumn 39, Issue 2, 2012, Pages 137-142

  Griman, Pedro ^a   Moran, Yeinmy ^a   Valero, Gabriela ^b   Loreto, Mariana ^b   Borjas, Lisbeth ^c   Chiurillo, Miguel A ^a  

^a UNIVERSIDAD CENTROCCIDENTAL LISANDRO ALVARADO   (Venezuela)

^b Ambulatorio Rural Wonken ^*  (Venezuela)

^c UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

CYP2D6 polymorphism; Inter ethnic differences; Pharmacogenetics; Venezuelan population

Indexed keywords

CYTOCHROME P450 2D6;

ANTHROPOLOGY; BIOGEOGRAPHICAL REGION; BIOTRANSFORMATION; CANCER; DISEASE PREVALENCE; DRUG; ETHNIC GROUP; GENE; METABOLISM; URBAN POPULATION;

AMERICAN INDIAN; ARTICLE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; HUMAN; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; RACE; URBAN POPULATION; VENEZUELA;

CONTINENTAL POPULATION GROUPS; CYTOCHROME P-450 CYP2D6; GENE FREQUENCY; HUMANS; INDIANS, SOUTH AMERICAN; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; URBAN POPULATION; VENEZUELA;

VENEZUELA;

EID: 84856898807     PISSN: 03014460     EISSN: 14645033     Source Type: Journal    
DOI: 10.3109/03014460.2012.656703     Document Type: Article

References (37)

1. Agundez JA, Ramirez R, Hernandez M, Llerena A, Bentez J. 1997. Molecular heterogeneity at the CYP2D gene locus in Nicaraguans: impact of gene-flow from Europe. Pharmacogenetics 7:337-740.
2. Bailliet G, Santos MR, Alfaro EL, Dipierri JE, Demarchi DA, Carnese FR, Bianchi NO. 2007. Allele and genotype frequencies of metabolic genes in Native Americans from Argentina and Paraguay. Mutat Res 627:171-177.
3. Bortolini MC, Salzano FM, Bau CH, Layrisse Z, Petzl-Erler ML, Tsuneto LT, Hill K, Hurtado AM, Castro-De-Guerra D, Bedoya G, Ruiz-Linares A. 2002. Y-chromosome biallelic polymorphisms and Native American population structure. Ann Hum Genet 66: 255-259. (Pubitemid 35256443)
4. Bortolini MC, Salzano FM, Thomas MG, Stuart S, Nasanen SP, Bau CH, Hutz MH, Layrisse Z, Petzl-Erler ML, Tsuneto LT, Hill K, Hurtado AM, Castro-de-Guerra D, Torres MM, Groot H, Michalski R, Nymadawa P, Bedoya G, Bradman N, Labuda D, Ruiz-Linares A. 2003. Y-chromosome evidence for differing ancient demographic histories in the Americas. Am J Hum Genet 73:524-539. (Pubitemid 37076267)
5. Bradford LD. 2002. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics 3: 229-243. (Pubitemid 34223859)
6. Brito F. 1966. Historia Economica y Social de Venezuela, una Estructura para su Estudio. Direccion de Cultura, Universidad Central de Venezuela, Caracas, Venezuela.
7. Crescenti A, Mas S, Gasso P, Baiget M, Bernardo M, Lafuente A. 2007. Simultaneous genotyping of CYP2D6*3,*4,*5 and*6 polymorphisms in a Spanish population through multiplex long polymerase chain reaction and minisequencing multiplex single base extension analysis. Clin Exp Pharmacol Physiol 34:992-997. (Pubitemid 47274547)
8. Evans WE, Relling MV. 2004. Moving towards individualized medicine with pharmacogenomics. Nature 429:464-468. (Pubitemid 38715141)
9. Fuselli S, de Filippo C, Mona S, Sistonen J, Fariselli P, Destro-Bisol G, Barbujani G, Bertorelle G, Sajantila A. 2010. Evolution of detoxifying systems: the role of environment and population history in shaping genetic diversity at human CYP2D6 locus. Pharmacogenet Genomics 20:485-499.
10. Gaedigk A, Bradford LD, Marcucci KA, Leeder JS. 2002. Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans. Clin Pharmacol Ther 72:76-89. (Pubitemid 34833189)
11. Gendzekhadze K, Herrera F, Montagnani S, Balbas O, Witter K, Albert E, Layrisse Z. 2004. HLA-DP polymorphism in Venezuelan Amerindians. Hum Immunol 65:1483-1488. (Pubitemid 39643230)
12. Guerra DC, Perez CF, Izaguirre MH, Barahona EA, Larralde AR, Lugo MV. 2011. Gender differences in ancestral contribution and admixture in Venezuelan populations. Hum Biol 83:345-361.
13. Hersberger M, Marti-Jaun J, Rentsch K, Hanseler E. 2000. Rapid detection of the CYP2D6*3, CYP2d6*4, and CYP2D6*6 alleles by tetraprimer PCR and of the CYP2D6*5 allele by multiplex long PCR. Clin Chem 46:1072-1077. (Pubitemid 30643307)
14. Human Cytochrome P450 (CYP) Allele Nomenclature Committee. Available online at www.cypalleles.ki.se/cyp2d6.htm, accessed 5 July 2011.
15. Ingelman-Sundberg M. 2005. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J 5:6-13. (Pubitemid 40220611)
16. Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C. 2007. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetics and clinical aspects. Pharmacol Ther 116:496-526. (Pubitemid 350116943)
17. Isaza CA, Henao J, Lo pez AM, Cacabelos R. 2000. Isolation, sequence and genotyping of the drug metabolizer CYP2D6 gene in the Colombian population. Methods Find Exp Clin Pharmacol 22: 695-705. (Pubitemid 32216825)
18. Jaja C, Burke W, Thummel K, Edwards K, Veenstra DL. 2008. Cytochrome p450 enzyme polymorphism frequency in indigenous and Native American populations: a systematic review. Community Genet 11:141-149. (Pubitemid 351465617)
19. Ji L, Pan S, Marti-Jaun J, Hanseler E, Rentsch K, Hersberger M. 2002a. Single step assay to analyze CYP2D6 gene polymorphism in Asian: allele frequency and a novel*14b allele in Mainland Chinese. Clin Chem 48:938-988.
20. Ji L, Pan S, Wu J, Marti-Jaun J, Hersberger M. 2002b. Genetic polymorphisms of CYP2D6 in Chinese mainland. Chin Med J 115: 1780-1784. (Pubitemid 36105051)
21. Jorge LF, Eichelbaum M, Griese EU, Inaba T, Arias TD. 1999. Comparative evolutionary pharmacogenetics of CYP2D6 in Ngawbe and Embera Amerindians of Panama and Colombia: role of selection versus drift in world populations. Pharmacogenetics 9: 217-228. (Pubitemid 29359004)
22. Jurima-Romet M, Foster BC, Casley WL, Rode A, Vloshinsky P, Huang HS, Geertsen S. 1997. CYP2D6-related oxidation polymorphism in a Canadian Inuit population. Can J Physiol Pharmacol 75:165-172. (Pubitemid 27254992)
23. Lewis MP, editor. 2009. Ethnologue: Languages of the World, 16th ed., Dallas, Texas: SIL international.
24. Lizarralde R, Beckerman S. 1982. Historia contemporanea de los bari. Antropolo gica 58:3-52.
25. Lopez M, Guerrero J, Jung-Cook H, Alonso ME. 2005. CYP2D6 genotype and phenotype determination in a Mexican Mestizo population. Eur J Clin Pharmacol 61:749-754. (Pubitemid 41674261)
26. Man M, Farmen M, Dumaual C, Teng CH, Moser B, Irie S, Noh GJ, Njau R, Close S, Wise S, Hockett R. 2010. Genetic variation in metabolizing enzyme and transporter genes: comprehensive assessment in 3 major East Asian subpopulations with comparison to Caucasians and Africans. J Clin Pharmacol 50:929-940.
27. Menoyo A, del Rio E, Baiget M. 2006. Characterization of variant alleles of cytochrome CYP2D6 in a Spanish population. Cell Biochem Funct 24:381-385. (Pubitemid 44379576)
28. Muñoz S, Vollrath V, Vallejos MP, Miquel JF, Covarrubias C, Raddatz A, Chianale J. 1998. Genetic polymorphisms of CYP2D6, CYP1A1 and CYP2E1 in the South-Amerindian population of Chile. Pharmacogenetics 8:343-351. (Pubitemid 28372328)
29. Neafsey P, Ginsberg G, Hattis D, Sonawane B. 2009. Genetic polymorphism in cytochrome P450 2D6 (CYP2D6): population distribution of CYP2D6 activity. J Toxicol Environ Health B Crit Rev 12:334-361.
30. Pardo-Govea T, Borjas L, Zabala W, Sanchez M, Portillo M, Aranguren A. 2007. Marcadores polimorficos del cromosoma-Y en grupos indgenas del estado Zulia. Venezuela. Ciencia 15:341-348.
31. Rodrguez-Larralde A, Castro de Guerra D, Gonzalez M, Morales J. 2001. Frecuencia genica y porcentaje de mezcla en diferentes areas geograficas de Venezuela, de acuerdo a los grupos Rh y ABO. Interciencia 26:8-12.
32. Shimizu T, Ochiai H, Asell F, Yokono Y, Kikuchi Y, Nitta M, Hama Y, Yamaguchi S, Hashimoto M, Taki K, Nakata K, Aida Y, Ohashi A, Ozawa N. 2003. Bioinformatics research on inter-racial difference in drug metabolism II. Analysis on relationship between enzyme activities of CYP2D6 and CYP2C19 and their relevant genotypes. Drug Metab Pharmacokinet 18:71-78.
33. Sistonen J, Fuselli S, Palo JU, Chauhan N, Padh H, Sajantila A. 2009. Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales. Pharmacogenet Genomics 19: 170-179.
34. Sistonen J, Sajantila A, Lao O, Corander J, Barbujani G, Fuselli S. 2007. CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure. Pharmacogenet Genomics 17:93-101.
35. Sosa-Macas M, Elizondo G, Flores-Perez C, Flores-Perez J, Bradley- Alvarez F, Alanis-Bañuelos RE, Lares-Asseff I. 2006. CYP2D6 genotype and phenotype in Amerindians of Tepehuano origin and Mestizos of Durango. Mexico. J Clin Pharmacol 46:527-536.
36. Suarez-Kurtz G, Pena SD. 2006. Pharmacogenomics in the Americas: the impact of genetic admixture. Curr Drug Targets 7:1649-1658. (Pubitemid 44873727)
37. Zhou SF. 2009. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part I. Clin Pharmacokinet 48:689-723.